Sinovac’s Sales of H1N1 Vaccine Now Top 20 Million Doses

Sinovac Biotech (北京科兴生物制品有限公司) has received the fifth order for its H1N1 vaccine, Panflu.1™, from China's Ministry of Industry and Information Technology. The latest order is for 8.57 million doses of the vaccine, bringing total Sinovac sales to 20 million doses. Sinovac must deliver 2.3 million doses by March 15, 2010, and the balance will be stockpiled in Sinovac’s warehouse. More details... Stock Symbol: (NSDQ: SVA)